On December 19, 2024, BioRay Pharmaceutical Co., Ltd. ('BioRay') announced that the National Medical Products Administration (NMPA) has accepted the clinical trial application for its self-developed C ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback